Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90499207
Filing Date:01/30/2021
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Curio Digital Therapeutics Inc
DBA/AKA/TA/FORMERLY
DBA Curio Digital Therapeutics Inc
INTERNAL ADDRESS
100 Overlook Drive Floor 2 Princeton NJ
*MAILING ADDRESS
100 Overlook Drive Floor 2 Princeton NJ
*CITY
Princeton
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
08540
PHONE
267-629-9674
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
http://curiodigitaltx.com/
LEGAL ENTITY INFORMATION
*TYPE
CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
042
*IDENTIFICATION
Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications;
Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the
field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in
the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of
postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various
life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of
prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic,
formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of
prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research
and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of
optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in
the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing
a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an
interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research;
Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website;
Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of
optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of
pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life
stages of women; Technology research in the field of behavioral health problems in various life stages of women
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90499207
Filing Date:01/30/2021
To the Commissioner for Trademarks:
MARK: Stella (Standard Characters, see mark)
The literal element of the mark consists of Stella. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Curio Digital Therapeutics Inc, DBA Curio Digital Therapeutics Inc, a corporation of Delaware, having an address of
100 Overlook Drive Floor 2 Princeton NJ
100 Overlook Drive Floor 2 Princeton NJ
Princeton, New Jersey 08540
United States
267-629-9674(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042: Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical
research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and
detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health
problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other
behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and
development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and
development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and
development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical
conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic
exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use
of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing
medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange
medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor
and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical
and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital
therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic,
formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of
postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women
Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file
showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a
stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.
In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 07/07/2020, and first used in commerce
at least as early as 07/07/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the
class of listed goods/services, consisting of a(n) Webpage.
Webpage URL: http://curiodigitaltx.com/
Webpage Date of Access: 01/29/2021
For informational purposes only, applicant's website address is: http://curiodigitaltx.com/
The applicant's current Correspondence Information:
Curio Digital Therapeutics Inc
PRIMARY EMAIL FOR CORRESPONDENCE: desk@patentwire.co.in
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): utkarsh@patentwire.co.in; sid@curiodigitaltx.com; k.shruti@patentwire.co.in; shailja@curiodigitaltx.com
The docket/reference number is 3075.
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Shailja Dixit/ Date: 01/30/2021
Signatory's Name: Shailja Dixit
Signatory's Position: CEO
Signatory's Phone Number: 267-629-9674
Signature method: Signed directly within the form
Payment Sale Number: 90499207
Payment Accounting Date: 02/01/2021
Serial Number: 90499207
Internet Transmission Date: Sat Jan 30 03:27:00 ET 2021
TEAS Stamp: USPTO/FTK-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210130032700755986-90499207-
7601990dff976aa24dfc9a2bb505e4e2364c0f02
66bb85f4cafd4678808cbc3751-CC-26580030-2
0210130025528661522